New Study Analyzes Sharp Rise in U.S. Drug Poisoning Deaths By County
Investigators look at the link between geographic patterns and death
rates in the new issue of the American Journal of Preventive Medicine
Investigators look at the link between geographic patterns and death rates in the new issue of the American Journal of Preventive Medicine
San Diego, CA, November 12, 2013
new study published in the American
Journal of Preventive Medicine gives new insight into the geographic
variation in drug poisoning mortality, with both urban centers and rural areas
showing a large increase in death rates. While previous studies have looked at
drug poisoning related deaths in broad strokes, this is the first study to
examine them on the county level across the entire U.S.
Drug poisoning is now the leading cause of injury death in the U.S. and has increased by more than 300 percent over the last three decades. Almost 90 percent of poisoning deaths can be attributed to illicit or licit drugs, with prescription drugs accounting for the majority of drug overdose deaths.
According to reports from the National Survey of Drug Use and Health, about 2.1 percent of Americans—or roughly 5 million people—have used prescription painkillers non-medically in the past month. The rise in drug-related deaths correlates to the increase in the non-medical use of prescription drugs, especially opioid analgesics.
While there have been some reports that suggest the rise in deaths has been sharper in rural areas than in urban centers, data to support the claim had never been fully substantiated. In this new study, investigators used small area estimation techniques to produce stable estimates of drug-related poisoning deaths at a county level, which revealed more information about how geography plays a role in death rates.
Using data obtained from the National Vital Statistics Multiple Cause of Death Files, investigators found that in 1999 only 3 percent of counties had annual drug poisoning age adjusted death rates (AADRs) over ten per 100,000, but found that the rate rose to 54 percent of counties by 2008. Additionally, while drug poisoning AADRs increased across all geographic areas both large and small, there was a greater percentage increase for rural areas (394 percent) compared to large metropolitan counties (297 percent).
"The interaction suggests that both central metropolitan and rural areas experienced similar absolute rates of increase in drug-poisoning AADRs from 1999 to 2009 and that these rates were more rapid than those seen in fringe or small metropolitan or micropolitan areas," explains lead investigator Lauren M. Rossen, PhD, MS. "However, since the AADRs in rural areas were substantially lower in 1999 as compared to central cities, the percentage increase was larger for rural areas over time."
The study also reveals regional trends in drug poisoning related deaths. "Maps of drug-poisoning mortality over time illustrated that AADRs greater than 29 per 100,000 per year were largely concentrated in Appalachian counties in 1999-2000; by 2008-2009, counties across the entire U.S. displayed AADRs of more than 29 per 100,000 per year," said Rossen. "These high rates could be seen in Alaska, Hawaii, the entire Pacific region, New Mexico, Oklahoma, Appalachia, the southern coasts of Louisiana and Mississippi, Florida, and across New England."
"Mapping death rates associated with drug poisoning at the county level may help elucidate geographic patterns, highlight areas where drug-related poisoning deaths are higher than expected, and inform policies and programs designed to address the increase in drug-poisoning mortality and morbidity," added Rossen.
# # #
Notes for editors
"Trends and Geographic Patterns in Drug-Poisoning Death Rates in the U.S., 1999-2009," by Lauren M Rossen, PhD, MS; Diba Khan, PhD; and Margaret Warner, PhD, is available online as of November 12, 2013 at www.ajpmonline.org and in print in the American Journal of Preventive Medicine, Volume 45, Issue 6 (December 2013), DOI 10.1016/j.amepre.2013.07.012.
Full text of the article is available to credentialed journalists upon request; contact Beverly Lytton at +1 858 534 9340 or eAJPM@ucsd.edu. Journalists wishing to interview the authors should contact Lauren M. Rossen, PhD, MS, at email@example.com.
About the American Journal of Preventive Medicine
The American Journal of Preventive Medicine (www.ajpmonline.org) is the official journal of The American College of Preventive Medicine (www.acpm.org) and the Association for Prevention Teaching and Research (http://www.aptrweb.org/). It publishes articles in the areas of prevention research, teaching, practice and policy. Original research is published on interventions aimed at the prevention of chronic and acute disease and the promotion of individual and community health. The journal features papers that address the primary and secondary prevention of important clinical, behavioral and public health issues such as injury and violence, infectious disease, women's health, smoking, sedentary behaviors and physical activity, nutrition, diabetes, obesity, and alcohol and drug abuse. Papers also address educational initiatives aimed at improving the ability of health professionals to provide effective clinical prevention and public health services. The journal also publishes official policy statements from the two co-sponsoring organizations, health services research pertinent to prevention and public health, review articles, media reviews, and editorials.
The American Journal of Preventive Medicine, with an Impact Factor of 3.945, is ranked 15th out of 158 Public, Environmental, and Occupational Health titles and 18th out of 151 General & Internal Medicine titles according to the 2012 Journal Citation Reports® published by Thomson Reuters.
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com
+1 858 534 9340